Develops drugs for RAS-addicted cancers.
Dec 2025Revenue $0.00/yrExpenses $1.18B/yr
No trendCash runway ≈ 3.2 years from Jun 2026
Figures by year
When will Revolution Medicines be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $1.18B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $1.18B | −$1.18B |
| Dec 2024 | $0.00 | $690M | −$690M |
| Dec 2023 | $11.6M | $499M | −$487M |
| Dec 2022 | $35.4M | $294M | −$258M |
| Dec 2021 | $29.4M | $217M | −$188M |
| Dec 2020 | $43.0M | $154M | −$111M |
| Dec 2019 | $50.0M | $104M | −$54.1M |
| Dec 2018 | $20.2M | $60.5M | −$40.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.